Doxorubicin Hydrochloride Injection IP

Name: Doxorubicin Hydrochloride Injection IP
Brand: NEETCO BIOPHARMA
Price: 975 INR
Availability: InStock

Price 975 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

Doxorubicin Hydrochloride Injection IP Specification

Indication
Used in the treatment of various cancers including breast cancer, bladder cancer, lymphoma, and leukemia

Dosage Form
Injection

Salt Composition
Doxorubicin Hydrochloride

Feature
Sterile, single-use vial, cytotoxic agent

Ingredients
Doxorubicin Hydrochloride, Water for injection, excipients

Application
Antineoplastic agent for intravenous administration

Ph Level
Approximately 3.0

Physical Color/Texture
Clear red solution

Fermentation Smell
Odorless

Storage Instructions
Store between 2C to 8C, protect from light

Shelf Life
24 months

Import/Export Status
Export quality available

Presentation
10 mg/5 ml vial, 50 mg/25 ml vial

Brand Name
As per manufacturer

Packaging Type
Glass vial with rubber stopper and aluminum seal

Compatibility
Compatible with most standard IV fluids (verify before use)

Route of Administration
Intravenous

Precautions
For hospital use only, handle with cytotoxic precautions

Solubility
Completely soluble in water

Container Material
Type I glass

About Doxorubicin Hydrochloride Injection IP

Doxorubicin Hydrochloride Injection IP is an illustrious antineoplastic agent, renowned for its phenomenal efficacy in cancer care. Now available at reduced rates during our exclusive sale, this immaculate solution is consistently in demand among healthcare professionals. Presented in convenient 10 mg/5 ml and 50 mg/25 ml glass vials, this cytotoxic injection is for intravenous administration in hospital settings only. It offers complete water solubility, exceptional compatibility with IV fluids (verify before use), and is protected by a Type I glass container for export-quality assurance. Shelf life: 24 months. Export, supply, and distribution from India.

Application and Directions for Doxorubicin Hydrochloride Injection IP

This injection is designed for use in hospital environments, specifically at oncology treatment sites under professional supervision. As a potent antineoplastic agent, Doxorubicin Hydrochloride is intravenously administered, as directed by a licensed medical practitioner. It is critical to handle with standard cytotoxic precautions, ensuring the product is only applied where precise cancer treatment regimens are indicated. Always follow professional direction for dosage and administration protocols.

Sample Policy, Export Markets, and Delivery Details

Our Doxorubicin Hydrochloride Injection IP samples are dispatched upon request, adhering to a premium, customer-oriented policy for evaluation purposes. Main export markets include nations across Asia, Africa, Europe, and the Middle East. Products are shipped from India's leading FOB ports, with prompt delivery timelines. As a distributor and exporter, we ensure that every shipment meets immaculate export standards, providing unparalleled support and reliability.

FAQ's of Doxorubicin Hydrochloride Injection IP:

Q: How should Doxorubicin Hydrochloride Injection IP be administered?

A: Doxorubicin Hydrochloride Injection IP is intended for intravenous use under strict medical supervision within hospital environments. The dosage and duration are determined by a licensed healthcare professional based on patient-specific therapy requirements.

Q: What are the main indications for this injectable?

A: This medication is used in the treatment of various cancers, including breast cancer, lymphoma, leukemia, and bladder cancer, making it a cornerstone in antineoplastic therapy regimens.

Q: When is the product dispatched after placing an order?

A: Orders for Doxorubicin Hydrochloride Injection IP are promptly dispatched following order confirmation and completion of required documentation, depending on stock availability and shipping destination.

Q: Where is the best site for application of this injection?

A: The product must be administered in a clinical or hospital setting by trained healthcare professionals using intravenous methods to ensure safety and efficacy.

Q: What precautions should be taken while handling this injection?

A: As a cytotoxic agent, this product should be handled with gloves and protective equipment. Only trained personnel should prepare and administer the injection, following hospital cytotoxic safety protocols.

Tell us about your requirement